Figure 3
From: Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis
Effects of WX-UK1, Galaradin ® , and Celecoxib ® on matrigel transmigration of tumour cells. (A) Shown are mean of invasion/migration ratios with standard deviation from three independent experiments. FaDu and HeLa cells were treated with WK-UK1® (SPI), triple combination of WX-UK1, Galaradin®, and Celecoxib®, or kept untreated (control). (B) Representative images of FaDu and HeLa cells after matrigel transmigration in the absence (left panels) or presence of WX-UK1, Galaradin®, and Celecoxib® are shown (right panels). (C) Same experiments as in (A) with supernatants from primary fibroblasts derived from hypopharynx carcinoma samples. Shown are mean of invasion/migration ratios with standard deviation from three independent experiments.